Related Experiment Video
Updated: Jul 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Importance of p53 for cancer onset and therapy
1Department of Hematology, Hadassah University Hospital, Jerusalem, Israel.
Abstract:
Cancer predisposition, onset and therapeutic response can be critically determined by the integrity of the tumor suppressor p53. The majority of human cancers appear to exhibit either abnormal p53 or disrupted p53 activation pathways. Intervention to restore wild-type p53 activities is an attractive approach for cancer therapy. The manipulation of p53 and its targets is a challenging field that is still in its infancy, but witnessing some notable developments in the areas of p53 gene therapy, mutant reactivation and suppression of the negative p53 regulator Mdm2 using small molecules. In addition, wild-type p53 manipulation in healthy tissues of cancer patients in the context of chemotherapy and radiation therapies is offering the potential of enhanced patient recovery.
Insights
Restoring the tumor suppressor p53 protein
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tumor suppressor p53 protein is critical for preventing cancer.
- Most human cancers involve abnormal p53 or its signaling pathways.
- Restoring wild-type p53 function is a promising cancer therapy strategy.
Purpose of the Study:
- To explore therapeutic strategies targeting the p53 pathway in cancer.
- To review recent developments in p53-based cancer interventions.
- To assess the potential of manipulating p53 for enhanced cancer treatment and recovery.
Main Methods:
- Review of current research in p53 gene therapy.
- Analysis of methods for mutant p53 reactivation.
- Investigation of small molecule inhibitors targeting Mdm2, a negative regulator of p53.
- Exploration of wild-type p53 manipulation in conjunction with chemotherapy and radiation.
Main Results:
- Significant progress has been made in p53 gene therapy and mutant p53 reactivation.
- Small molecule inhibitors targeting Mdm2 show promise in restoring p53 activity.
- Manipulating wild-type p53 in healthy tissues may improve patient recovery during cancer treatment.
Conclusions:
- Targeting the p53 pathway represents a developing but significant area in cancer therapy.
- Various approaches, including gene therapy, mutant reactivation, and Mdm2 inhibition, are advancing.
- Modulating p53 offers potential for both direct anti-cancer effects and supportive care to improve treatment outcomes.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

